First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran

M. Shamaei, P. Tabarsi, M. Marjani, E. Chitsaz, D. Mansouri, M. R. Masjedi, P. Baghaei (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Session: Clinical epidemiology of tuberculosis III
Session type: Thematic Poster Session
Number: 2492
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shamaei, P. Tabarsi, M. Marjani, E. Chitsaz, D. Mansouri, M. R. Masjedi, P. Baghaei (Tehran, Islamic Republic Of Iran). First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran. Eur Respir J 2008; 32: Suppl. 52, 2492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009

Second-line tuberculosis drug resistance study from a referal center of Turkey
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008


Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Resistance to second-line antituberculous drugs of Mtb strains in TB institute clinic
Source: Eur Respir J 2007; 30: Suppl. 51, 442s
Year: 2007

Antituberculosis drug resistance in a secondary care hospital in Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


The association between HIV and antituberculosis drug resistance
Source: Eur Respir J 2008; 32: 718-725
Year: 2008



A Cuban successful history on antituberculosis treatment and drug resistance surveillance
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

MDR-TB treatment in prison setting
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007


Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 359s
Year: 2002

Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002

A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018


Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


MDR-TB and XDR-TB: drug resistance and treatment outcomes
Source: Eur Respir J 2009; 34: 778
Year: 2009


Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007



Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013